Presentations
°ANGIOGENIN LEVELS IN CSF AND SERUM by Dr. J. Phukan
°AGGREGATION OF NEURODEGENERATIVE DISEASE IN IRISH ALS FAMILIES by P. Brennan
°ETHNIC VARIATION IN FREQUENCY AND CLINICAL FEATURES OF ALS:
ANALYSIS OF A TERTIARY CLINIC-BASED COHORT IN HAVANA, CUBA by T.Zaldivar
°ASSOCIATION BETWEEN RNASE A SUPERFAMILY MEMBERS AND SPORADIC ALS by S. Cronin
°SCREENING HYPOXIA GENES IN SPORADIC ALS IN TWO EUROPEAN POPULATIONS by S. Cronin
°A POPULATION BASED SURVEY OF COGNITIVE DECLINE IN ALS by J. Phukan
°END-OF-LIFE DECISIONS AND ADVANCE DIRECTIVES IN MOTOR NEURONE DISEASE:
IS THE PATIENT EVER TRULY AUTONOMOUS? by B. Corr
°ANG LOCUS HAPLOTYPES IN TWO EUROPEAN POPULATIONS by S. Cronin
°CLINICAL CHARACTERIZATION AND INTERVENTION IN ALS: A COMPARTIVE STUDY
OF TWO COHORTS by P. Brennan
